{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:41:45Z","timestamp":1792543305498,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":2668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008658","name":"German Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3945\/ajcn.114.101964","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T02:54:22Z","timestamp":1444272862000},"page":"1014-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status"],"prefix":"10.1016","volume":"102","author":[{"given":"Wulf","family":"Hildebrandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bonaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus A","family":"Dugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Edler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kinscherf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.114.101964_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"key":"10.3945\/ajcn.114.101964_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.3945\/ajcn.114.101964_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.114.101964_bib4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.3945\/ajcn.114.101964_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat Med"},{"key":"10.3945\/ajcn.114.101964_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nyg\u00e5rd","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.114.101964_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","article-title":"Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study","volume":"274","author":"Nyg\u00e5rd","year":"1995","journal-title":"JAMA"},{"key":"10.3945\/ajcn.114.101964_bib8","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1160\/TH09-06-0393","article-title":"Homocysteine and arterial thrombosis: challenge and opportunity","volume":"103","author":"Di Minno","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.3945\/ajcn.114.101964_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1172\/JCI10588","article-title":"Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model","volume":"107","author":"Hofmann","year":"2001","journal-title":"J Clin Invest"},{"key":"10.3945\/ajcn.114.101964_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.freeradbiomed.2008.11.002","article-title":"Homocysteine and inflammation as main determinants of oxidative stress in the elderly","volume":"46","author":"Ventura","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/ajcn.114.101964_bib11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.100.11.1161","article-title":"Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans","volume":"100","author":"Kanani","year":"1999","journal-title":"Circulation"},{"key":"10.3945\/ajcn.114.101964_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","article-title":"Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure","volume":"109","author":"Scholze","year":"2004","journal-title":"Circulation"},{"key":"10.3945\/ajcn.114.101964_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.12.037","article-title":"Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study","volume":"159","author":"Page","year":"2010","journal-title":"Am Heart J"},{"key":"10.3945\/ajcn.114.101964_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","article-title":"Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis","volume":"332","author":"Selhub","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.114.101964_bib15","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.3945\/ajcn.114.101964_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.3945\/ajcn.114.101964_bib17","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"1","author":"Mart\u00ed-Carvajal","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3945\/ajcn.114.101964_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1742-1241.2009.02207.x","article-title":"Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials","volume":"64","author":"Mei","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.3945\/ajcn.114.101964_bib19","doi-asserted-by":"crossref","first-page":"e1001177","DOI":"10.1371\/journal.pmed.1001177","article-title":"Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias","volume":"9","author":"Clarke","year":"2012","journal-title":"PLoS Med"},{"key":"10.3945\/ajcn.114.101964_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.3945\/ajcn.114.101964_bib21","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.STR.25.10.1924","article-title":"A prospective study of plasma homocyst(e)ine and risk of ischemic stroke","volume":"25","author":"Verhoef","year":"1994","journal-title":"Stroke"},{"key":"10.3945\/ajcn.114.101964_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(12)70091-1","article-title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3945\/ajcn.114.101964_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1742-1241.2012.02929.x","article-title":"Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis","volume":"66","author":"Huo","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.3945\/ajcn.114.101964_bib24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.3945\/ajcn.114.101964_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.jrn.2011.10.008","article-title":"Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies","volume":"22","author":"Perna","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.3945\/ajcn.114.101964_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V99.5.1552","article-title":"Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity","volume":"99","author":"Hildebrandt","year":"2002","journal-title":"Blood"},{"key":"10.3945\/ajcn.114.101964_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00365519409085464","article-title":"Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine","volume":"54","author":"Hultberg","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"key":"10.3945\/ajcn.114.101964_bib28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/jps.20680","article-title":"Thiol exchange: an in vitro assay that predicts the efficacy of novel homocysteine lowering therapies","volume":"95","author":"Urquhart","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.3945\/ajcn.114.101964_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/phrs.1999.0519","article-title":"N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion","volume":"40","author":"Ventura","year":"1999","journal-title":"Pharmacol Res"},{"key":"10.3945\/ajcn.114.101964_bib30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"10.3945\/ajcn.114.101964_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0021-9150(95)05635-1","article-title":"N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels","volume":"119","author":"Wiklund","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.3945\/ajcn.114.101964_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000069535","article-title":"Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy","volume":"68","author":"Ventura","year":"2003","journal-title":"Pharmacology"},{"key":"10.3945\/ajcn.114.101964_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/ajkd.2003.50054","article-title":"The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.114.101964_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/dc07-2251","article-title":"Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes","volume":"31","author":"Martina","year":"2008","journal-title":"Diabetes Care"},{"key":"10.3945\/ajcn.114.101964_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00109-004-0532-5","article-title":"Effect of thiol antioxidant on body fat and insulin reactivity","volume":"82","author":"Hildebrandt","year":"2004","journal-title":"J Mol Med (Berl)"},{"key":"10.3945\/ajcn.114.101964_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.freeradbiomed.2003.07.001","article-title":"Cholesterol levels linked to abnormal plasma thiol concentrations and thiol\/disulfide redox status in hyperlipidemic subjects","volume":"35","author":"Kinscherf","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/ajcn.114.101964_bib37","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0891-5849(00)00424-X","article-title":"Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers: chronic obstructive pulmonary disease","volume":"29","author":"T\u00e4ger","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"7285","key":"10.3945\/ajcn.114.101964_bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.322.7285.531","article-title":"Blood pressure measuring devices: recommendations of the European Society of Hypertension","volume":"322","author":"O\u2019Brien","year":"2001","journal-title":"BMJ"},{"key":"10.3945\/ajcn.114.101964_bib39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal Biochem"},{"key":"10.3945\/ajcn.114.101964_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.3945\/ajcn.114.101964_bib41","first-page":"1015","article-title":"The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers","volume":"4","author":"Sela","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.3945\/ajcn.114.101964_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/CS20030052","article-title":"N-acetylcysteine improves the disturbed thiol redox balance after methionine loading","volume":"105","author":"Raijmakers","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.3945\/ajcn.114.101964_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000070032","article-title":"Influence of training volume and acute physical exercise on the homocysteine levels in endurance-trained men: interactions with plasma folate and vitamin B12","volume":"47","author":"K\u00f6nig","year":"2003","journal-title":"Ann Nutr Metab"},{"key":"10.3945\/ajcn.114.101964_bib44","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/jn\/131.4.1214","article-title":"Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Hhomocysteine Study","volume":"131","author":"Nurk","year":"2001","journal-title":"J Nutr"},{"key":"10.3945\/ajcn.114.101964_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/ajcn.114.101964_bib46","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1291\/hypres.29.1021","article-title":"Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats","volume":"29","author":"Zicha","year":"2006","journal-title":"Hypertens Res"},{"key":"10.3945\/ajcn.114.101964_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/phrs.1993.1124","article-title":"Dose-related increase of HDL-cholesterol levels after N-acetylcysteine in man","volume":"28","author":"Franceschini","year":"1993","journal-title":"Pharmacol Res"},{"key":"10.3945\/ajcn.114.101964_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00280-6","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME study","volume":"170","author":"Luc","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.3945\/ajcn.114.101964_bib49","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI116778","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells","volume":"92","author":"Marui","year":"1993","journal-title":"J Clin Invest"},{"key":"10.3945\/ajcn.114.101964_bib50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1513\/pats.201001-014AW","article-title":"Cellular response to cigarette smoke and oxidants: adapting to survive","volume":"7","author":"Cantin","year":"2010","journal-title":"Proc Am Thorac Soc"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523137397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523137397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/102\/5\/1014\/23757506\/ajcn101964.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:55:03Z","timestamp":1685361303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523137397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0002916523137397"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.114.101964","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.114.101964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}